Tenet Healthcare (THC) Tops Q3 EPS by 36c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $3.70, $0.36 better than the analyst estimate of $3.34. Revenue for the quarter came in at $5.29 billion versus the consensus estimate of $5.26 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $15.93-$16.26, versus the consensus of $15.83. Tenet Healthcare sees FY2025 revenue of $21.15-21.35 billion, versus the consensus of $21.147 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance